As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

The stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY ...

You’ll work with your healthcare provider to learn about the best and worst foods to eat while on a GLP-1 weight loss ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

Developed initially to manage diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have skyrocketed in popularity ...

News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...

Research identifies key factors affecting semaglutide initiation among obese individuals without diabetes, revealing ...

Debate over the risks and benefits of the population weight loss drugs like Ozempic, Wegovy, and Zepbound finally came to an ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues, including ...

A Georgia woman who lost 60 pounds taking semaglutide spent nearly $20,000 on a 'mommy makeover' only to pile the weight back ...